These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 22578718

  • 1. Glucocorticoid receptor signaling in bone cells.
    Moutsatsou P, Kassi E, Papavassiliou AG.
    Trends Mol Med; 2012 Jun; 18(6):348-59. PubMed ID: 22578718
    [Abstract] [Full Text] [Related]

  • 2. Selective glucocorticoid receptor modulation maintains bone mineral density in mice.
    Thiele S, Ziegler N, Tsourdi E, De Bosscher K, Tuckermann JP, Hofbauer LC, Rauner M.
    J Bone Miner Res; 2012 Nov; 27(11):2242-50. PubMed ID: 22714558
    [Abstract] [Full Text] [Related]

  • 3. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.
    Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt-Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss MM, Angel PE, Lerner UH, David JP, Reichardt HM, Amling M, Schütz G, Tuckermann JP.
    Cell Metab; 2010 Jun 09; 11(6):517-31. PubMed ID: 20519123
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes.
    Brabnikova Maresova K, Pavelka K, Stepan JJ.
    Calcif Tissue Int; 2013 Apr 09; 92(4):354-61. PubMed ID: 23247536
    [Abstract] [Full Text] [Related]

  • 6. Strontium ranelate affects signaling from mechanically-stimulated osteocytes towards osteoclasts and osteoblasts.
    Bakker AD, Zandieh-Doulabi B, Klein-Nulend J.
    Bone; 2013 Mar 09; 53(1):112-9. PubMed ID: 23234812
    [Abstract] [Full Text] [Related]

  • 7. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
    Buttgereit F, Zhou H, Kalak R, Gaber T, Spies CM, Huscher D, Straub RH, Modzelewski J, Dunstan CR, Seibel MJ.
    Arthritis Rheum; 2009 Jul 09; 60(7):1998-2007. PubMed ID: 19565501
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
    Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC.
    J Clin Invest; 1998 Jul 15; 102(2):274-82. PubMed ID: 9664068
    [Abstract] [Full Text] [Related]

  • 9. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H, Berger M, Rehwinkel H, Asadullah K.
    Mol Cell Endocrinol; 2007 Sep 15; 275(1-2):109-17. PubMed ID: 17630119
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.
    O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS.
    Endocrinology; 2004 Apr 15; 145(4):1835-41. PubMed ID: 14691012
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
    Wiren KM, Toombs AR, Semirale AA, Zhang X.
    Bone; 2006 May 15; 38(5):637-51. PubMed ID: 16413235
    [Abstract] [Full Text] [Related]

  • 14. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M.
    APMIS Suppl; 1997 May 15; 71():1-30. PubMed ID: 9357492
    [Abstract] [Full Text] [Related]

  • 15. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R, Takeda M, Miyoshi T, Inagaki K, Sada KE, Makino H.
    Mol Cell Endocrinol; 2010 Aug 30; 325(1-2):118-27. PubMed ID: 20638987
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment.
    Chen TL.
    Bone; 2004 Jul 30; 35(1):83-95. PubMed ID: 15207744
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
    Li M, Saito T, Amizuka N.
    Clin Calcium; 2008 Mar 30; 18(3):328-35. PubMed ID: 18310820
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of glucocorticoid action in bone cells.
    Delany AM, Dong Y, Canalis E.
    J Cell Biochem; 1994 Nov 30; 56(3):295-302. PubMed ID: 7876321
    [Abstract] [Full Text] [Related]

  • 20. Colocalization of glucocorticoid and mineralocorticoid receptors in human bone.
    Beavan S, Horner A, Bord S, Ireland D, Compston J.
    J Bone Miner Res; 2001 Aug 30; 16(8):1496-504. PubMed ID: 11499872
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.